Key highlights Tirzepatide (also known by FDA-approved brand names Mounjaro and Zepbound) is a dual receptor agonist (GLP-1/GIP) that helps reduce appetite, control blood sugar, and promote greater weight loss than single receptor GLP-1 receptor agonists, such as semaglutide
Importantly, no significant impact on food intake and no observable adverse effects were reported, suggesting a metabolic rather than appetite-mediated mechanism of action
Scroll to continue reading If youre wondering, as I did, how to find out whether youre B12 deficient, dont waste your time
They act as specific signaling molecules that mimic the human body's endogenous hormones to regulate biological processes
But having a clear, practical plan can replace that anxiety with action